Why the study?
Does a malignant diagnosis increase the rate and alter the pattern of 90-day readmission after hepato-pancreatic surgery compared to a benign diagnosis?
Does a malignant diagnosis increase the rate and alter the pattern of 90-day readmission after hepato-pancreatic surgery compared to a benign diagnosis?
Following hepato-pancreatic surgery, patients with a malignant diagnosis have a slightly higher 90-day readmission rate and are significantly more likely to be readmitted to a non-index hospital compared to those with a benign diagnosis.
Authors
No takes yet. Share an insight, caveat, or question.
Malignant diagnosis was associated with higher non-index readmissions after hepato-pancreatic surgery; hypothesis-generating for care coordination interventions.
Bagante et al. (2018) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: